I don’t think csl would invest billions in something “just nice to have” . Take up your argument about the commerciality of their multi billion dollar , decades in development , project , with the company. Or if you think CSl are that naive I suggest you concentrate your efforts analysing a different company.
Garadacimab and csl112, page-12
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$289.00 |
Change
0.000(0.00%) |
Mkt cap ! $139.6B | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 177 | $317.93 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $260.07 | 962 | 16 |
View Market Depth
| Last trade - 09.48am 11/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$285.30 |
Change
0.000 ( 1.25 %) |
||||
| Open | High | Low | Volume | ||
| $285.73 | $285.78 | $284.28 | 206 | ||
| Last updated 10.08am 11/06/2024 ? | |||||
| CSL (ASX) Chart |
Day chart unavailable